View Past PerformanceYcchem バランスシートの健全性財務の健全性 基準チェック /26Ycchemの総株主資本は₩49.7B 、総負債は₩77.5Bで、負債比率は156%となります。総資産と総負債はそれぞれ₩161.4Bと₩111.7Bです。 Ycchemの EBIT は₩1.1Bで、利息カバレッジ比率0.4です。現金および短期投資は₩34.3Bです。主要情報156.03%負債資本比率₩77.55b負債インタレスト・カバレッジ・レシオ0.4x現金₩34.27bエクイティ₩49.70b負債合計₩111.67b総資産₩161.37b財務の健全性に関する最新情報分析記事 • Jul 10Would Ycchem (KOSDAQ:112290) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jul 30Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,720, the stock trades at a trailing P/E ratio of 22.4x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 18% over the past three years.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₩9,100, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 39% over the past three years.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩10,850, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 63% over the past three years.分析記事 • May 27We Think Shareholders Should Be Aware Of Some Factors Beyond Ycchem's (KOSDAQ:112290) ProfitEven though Ycchem Co., Ltd. ( KOSDAQ:112290 ) posted strong earnings recently, the stock hasn't reacted in a large...Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩16,550, the stock trades at a trailing P/E ratio of 72.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 175% over the past three years.Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩14,050, the stock trades at a trailing P/E ratio of 61.4x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.Board Change • Apr 29Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Apr 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.0% operating cash flow to total debt). High level of non-cash earnings (20% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩21,500, the stock trades at a trailing P/E ratio of 47x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 44% over the past three years.New Risk • Mar 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 2.0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.0% operating cash flow to total debt). High level of non-cash earnings (20% accrual ratio).New Risk • Mar 20New major risk - Revenue and earnings growthEarnings have declined by 62% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.お知らせ • Mar 17Ycchem Co., Ltd., Annual General Meeting, Mar 27, 2026Ycchem Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 174-12, yuseori-gil, seonnam-myeon, seongju-gun, gyeongsangbuk-do, South Korea分析記事 • Jan 26Ycchem Co., Ltd. (KOSDAQ:112290) Not Lagging Industry On Growth Or PricingYcchem Co., Ltd.'s ( KOSDAQ:112290 ) price-to-sales (or "P/S") ratio of 3.1x may look like a poor investment...分析記事 • Dec 01Should You Investigate Ycchem Co., Ltd. (KOSDAQ:112290) At ₩21,150?Ycchem Co., Ltd. ( KOSDAQ:112290 ), is not the largest company out there, but it saw a decent share price growth of 12...Buy Or Sell Opportunity • Nov 21Now 22% undervaluedOver the last 90 days, the stock has risen 2.4% to ₩19,100. The fair value is estimated to be ₩24,446, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Meanwhile, the company became loss making.分析記事 • Nov 03Calculating The Intrinsic Value Of Ycchem Co., Ltd. (KOSDAQ:112290)Key Insights Ycchem's estimated fair value is ₩24,802 based on 2 Stage Free Cash Flow to Equity With ₩25,500 share...お知らせ • Oct 15+ 1 more updateYcchem Co., Ltd. announced that it has received KRW 11 billion in fundingOn October 14, 2025, Ycchem Co., Ltd. closed the transaction.New Risk • Oct 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.分析記事 • Sep 12Ycchem Co., Ltd.'s (KOSDAQ:112290) Share Price Matching Investor OpinionYcchem Co., Ltd.'s ( KOSDAQ:112290 ) price-to-sales (or "P/S") ratio of 3x may look like a poor investment opportunity...Buy Or Sell Opportunity • Aug 26Now 23% overvaluedOver the last 90 days, the stock has fallen 14% to ₩20,450. The fair value is estimated to be ₩16,623, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Aug 04Now 20% overvaluedOver the last 90 days, the stock has fallen 5.9% to ₩19,810. The fair value is estimated to be ₩16,451, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making.分析記事 • Jul 10Would Ycchem (KOSDAQ:112290) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...お知らせ • Mar 14Ycchem Co., Ltd., Annual General Meeting, Mar 28, 2025Ycchem Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 174-12, yuseori-gil, seonnam-myeon, seongju-gun, gyeongsangbuk-do, South KoreaNew Risk • Nov 12New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩137.9b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩137.9b market cap, or US$98.1m).New Risk • Sep 06New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$97.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₩128.9b market cap, or US$97.1m).New Risk • Mar 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change).New Risk • Feb 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₩121.8b market cap, or US$91.4m).財務状況分析短期負債: A112290の 短期資産 ( ₩65.5B ) は 短期負債 ( ₩84.6B ) をカバーしていません。長期負債: A112290の短期資産 ( ₩65.5B ) が 長期負債 ( ₩27.1B ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: A112290の 純負債対資本比率 ( 87.1% ) は 高い と見なされます。負債の削減: A112290の負債対資本比率は、過去 5 年間で197.7%から156%に減少しました。債務返済能力: A112290の 営業キャッシュフロー はマイナスであるため、負債は十分にカバーされていません。インタレストカバレッジ: A112290の負債に対する 利息支払い は EBIT ( 0.4 x coverage) によって 十分にカバーされていません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YMaterials 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/13 14:35終値2026/08/13 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ycchem Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Yeong-Min KoDAOL Investment & Securities Co., Ltd.
分析記事 • Jul 10Would Ycchem (KOSDAQ:112290) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Jul 30Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩7,720, the stock trades at a trailing P/E ratio of 22.4x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 18% over the past three years.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₩9,100, the stock trades at a trailing P/E ratio of 26.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 39% over the past three years.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩10,850, the stock trades at a trailing P/E ratio of 31.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 63% over the past three years.
分析記事 • May 27We Think Shareholders Should Be Aware Of Some Factors Beyond Ycchem's (KOSDAQ:112290) ProfitEven though Ycchem Co., Ltd. ( KOSDAQ:112290 ) posted strong earnings recently, the stock hasn't reacted in a large...
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩16,550, the stock trades at a trailing P/E ratio of 72.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 175% over the past three years.
Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩14,050, the stock trades at a trailing P/E ratio of 61.4x. Average trailing P/E is 17x in the Chemicals industry in South Korea. Total returns to shareholders of 127% over the past three years.
Board Change • Apr 29Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Apr 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.0% operating cash flow to total debt). High level of non-cash earnings (20% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change).
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩21,500, the stock trades at a trailing P/E ratio of 47x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 44% over the past three years.
New Risk • Mar 27New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 2.0% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.0% operating cash flow to total debt). High level of non-cash earnings (20% accrual ratio).
New Risk • Mar 20New major risk - Revenue and earnings growthEarnings have declined by 62% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
お知らせ • Mar 17Ycchem Co., Ltd., Annual General Meeting, Mar 27, 2026Ycchem Co., Ltd., Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 174-12, yuseori-gil, seonnam-myeon, seongju-gun, gyeongsangbuk-do, South Korea
分析記事 • Jan 26Ycchem Co., Ltd. (KOSDAQ:112290) Not Lagging Industry On Growth Or PricingYcchem Co., Ltd.'s ( KOSDAQ:112290 ) price-to-sales (or "P/S") ratio of 3.1x may look like a poor investment...
分析記事 • Dec 01Should You Investigate Ycchem Co., Ltd. (KOSDAQ:112290) At ₩21,150?Ycchem Co., Ltd. ( KOSDAQ:112290 ), is not the largest company out there, but it saw a decent share price growth of 12...
Buy Or Sell Opportunity • Nov 21Now 22% undervaluedOver the last 90 days, the stock has risen 2.4% to ₩19,100. The fair value is estimated to be ₩24,446, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.0% over the last 3 years. Meanwhile, the company became loss making.
分析記事 • Nov 03Calculating The Intrinsic Value Of Ycchem Co., Ltd. (KOSDAQ:112290)Key Insights Ycchem's estimated fair value is ₩24,802 based on 2 Stage Free Cash Flow to Equity With ₩25,500 share...
お知らせ • Oct 15+ 1 more updateYcchem Co., Ltd. announced that it has received KRW 11 billion in fundingOn October 14, 2025, Ycchem Co., Ltd. closed the transaction.
New Risk • Oct 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
分析記事 • Sep 12Ycchem Co., Ltd.'s (KOSDAQ:112290) Share Price Matching Investor OpinionYcchem Co., Ltd.'s ( KOSDAQ:112290 ) price-to-sales (or "P/S") ratio of 3x may look like a poor investment opportunity...
Buy Or Sell Opportunity • Aug 26Now 23% overvaluedOver the last 90 days, the stock has fallen 14% to ₩20,450. The fair value is estimated to be ₩16,623, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Aug 04Now 20% overvaluedOver the last 90 days, the stock has fallen 5.9% to ₩19,810. The fair value is estimated to be ₩16,451, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making.
分析記事 • Jul 10Would Ycchem (KOSDAQ:112290) Be Better Off With Less Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
お知らせ • Mar 14Ycchem Co., Ltd., Annual General Meeting, Mar 28, 2025Ycchem Co., Ltd., Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 174-12, yuseori-gil, seonnam-myeon, seongju-gun, gyeongsangbuk-do, South Korea
New Risk • Nov 12New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩137.9b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩137.9b market cap, or US$98.1m).
New Risk • Sep 06New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$97.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (₩128.9b market cap, or US$97.1m).
New Risk • Mar 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change).
New Risk • Feb 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₩121.8b market cap, or US$91.4m).